Rubis: Transactions carried out within the framework of the share buyback programme (excluding transactions within the liquidity agreement) – 28 October to 1st November 2024 Read more about Rubis: Transactions carried out within the framework of the share buyback programme (excluding transactions within the liquidity agreement) – 28 October to 1st November 2024
PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S. Read more about PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.
Storebrand ASA Submitted by master_of_puppets on Mon 04/11/2024 - 17:55 Read more about Storebrand ASA
Storebrand ASA Submitted by master_of_puppets on Mon 04/11/2024 - 17:55 Read more about Storebrand ASA